Gartner (IT) Competitors $400.28 +4.84 (+1.22%) Closing price 07/3/2025 03:30 PM EasternExtended Trading$400.32 +0.04 (+0.01%) As of 07/3/2025 04:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IT vs. CCRN, DOCU, FORR, GOOG, ICFI, ACN, APTV, TRU, TT, and CTSHShould you be buying Gartner stock or one of its competitors? The main competitors of Gartner include Cross Country Healthcare (CCRN), Docusign (DOCU), Forrester Research (FORR), Alphabet (GOOG), ICF International (ICFI), Accenture (ACN), Aptiv (APTV), TransUnion (TRU), Trane Technologies (TT), and Cognizant Technology Solutions (CTSH). Gartner vs. Its Competitors Cross Country Healthcare Docusign Forrester Research Alphabet ICF International Accenture Aptiv TransUnion Trane Technologies Cognizant Technology Solutions Cross Country Healthcare (NASDAQ:CCRN) and Gartner (NYSE:IT) are both business services companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, risk, profitability, institutional ownership and earnings. Does the media prefer CCRN or IT? In the previous week, Gartner had 19 more articles in the media than Cross Country Healthcare. MarketBeat recorded 23 mentions for Gartner and 4 mentions for Cross Country Healthcare. Gartner's average media sentiment score of 0.74 beat Cross Country Healthcare's score of 0.06 indicating that Gartner is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cross Country Healthcare 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Gartner 13 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Do institutionals & insiders hold more shares of CCRN or IT? 96.0% of Cross Country Healthcare shares are owned by institutional investors. Comparatively, 91.5% of Gartner shares are owned by institutional investors. 4.9% of Cross Country Healthcare shares are owned by insiders. Comparatively, 2.3% of Gartner shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Do analysts rate CCRN or IT? Cross Country Healthcare currently has a consensus price target of $17.93, indicating a potential upside of 38.14%. Gartner has a consensus price target of $515.89, indicating a potential upside of 28.88%. Given Cross Country Healthcare's higher possible upside, research analysts plainly believe Cross Country Healthcare is more favorable than Gartner.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cross Country Healthcare 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Gartner 1 Sell rating(s) 3 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.44 Is CCRN or IT more profitable? Gartner has a net margin of 19.82% compared to Cross Country Healthcare's net margin of -1.41%. Gartner's return on equity of 96.70% beat Cross Country Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Cross Country Healthcare-1.41% 2.56% 1.84% Gartner 19.82%96.70%13.68% Which has more volatility & risk, CCRN or IT? Cross Country Healthcare has a beta of 0.36, meaning that its share price is 64% less volatile than the S&P 500. Comparatively, Gartner has a beta of 1.19, meaning that its share price is 19% more volatile than the S&P 500. Which has better earnings and valuation, CCRN or IT? Gartner has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Gartner, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCross Country Healthcare$1.34B0.32-$14.56M-$0.53-24.49Gartner$6.30B4.89$1.25B$16.0724.91 SummaryGartner beats Cross Country Healthcare on 13 of the 16 factors compared between the two stocks. Get Gartner News Delivered to You Automatically Sign up to receive the latest news and ratings for IT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IT vs. The Competition Export to ExcelMetricGartnerConsulting IndustryBusiness SectorNYSE ExchangeMarket Cap$30.81B$7.79B$13.16B$20.71BDividend YieldN/A1.62%2.54%3.71%P/E Ratio24.9125.8728.8928.08Price / Sales4.892.8940.2338.52Price / Cash23.6518.2126.8322.53Price / Book22.786.126.294.58Net Income$1.25B$272.15M$188.91M$985.54M7 Day Performance-0.60%3.18%3.77%2.79%1 Month Performance-5.22%-0.68%3.08%4.37%1 Year Performance-11.44%1.90%37.52%15.08% Gartner Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ITGartner4.77 of 5 stars$400.28+1.2%$515.89+28.9%-11.4%$30.81B$6.30B24.9121,044CCRNCross Country Healthcare3.842 of 5 stars$13.05+2.0%$17.93+37.4%-3.4%$427.78M$1.34B-24.628,205News CoverageDOCUDocusign4.7218 of 5 stars$77.89+1.9%$89.77+15.3%+45.0%$15.74B$2.98B14.726,838Insider TradeFORRForrester Research4.2544 of 5 stars$9.90+0.7%N/A-35.0%$188.69M$432.47M-2.171,571GOOGAlphabet4.8621 of 5 stars$177.39-0.5%$206.38+16.3%-6.1%$2.15T$359.71B19.78190,200Trending NewsInsider TradeHigh Trading VolumeICFIICF International4.4851 of 5 stars$84.71+0.5%$127.20+50.2%-33.9%$1.56B$2.02B14.539,300ACNAccenture4.9908 of 5 stars$298.92+1.2%$370.71+24.0%+1.8%$187.22B$64.90B23.80774,000Positive NewsAPTVAptiv4.8337 of 5 stars$68.15-0.9%$81.56+19.7%+3.2%$14.84B$19.71B11.28141,000News CoveragePositive NewsAnalyst ForecastTRUTransUnion4.6137 of 5 stars$88.05+0.9%$109.69+24.6%+20.1%$17.18B$4.18B46.8413,400Positive NewsAnalyst UpgradeTTTrane Technologies4.358 of 5 stars$437.55+1.2%$427.47-2.3%+32.5%$97.58B$19.84B36.4039,000News CoveragePositive NewsAnalyst ForecastCTSHCognizant Technology Solutions4.7126 of 5 stars$78.03+0.4%$85.00+8.9%+15.4%$38.46B$19.74B16.43355,300Positive News Related Companies and Tools Related Companies CCRN Alternatives DOCU Alternatives FORR Alternatives GOOG Alternatives ICFI Alternatives ACN Alternatives APTV Alternatives TRU Alternatives TT Alternatives CTSH Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:IT) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gartner, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gartner With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
